Charles Schwab’s Cantel Medical Corporation CMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-315,743
| Closed | -$25.2M | – | 3614 |
|
|
2021
Q1 | $25.2M | Sell |
315,743
-5,761
| -2% | -$450K | 0.01% | 1340 |
|
|
2020
Q4 | $25.4M | Buy |
321,504
+21,621
| +7% | +$1.27M | 0.01% | 1222 |
|
|
2020
Q3 | $13.2M | Buy |
299,883
+969
| +0.3% | +$47.7K | 0.01% | 1494 |
|
|
2020
Q2 | $13.2M | Buy |
298,914
+91,523
| +44% | +$3.41M | 0.01% | 1456 |
|
|
2020
Q1 | $7.45M | Buy |
207,391
+18
| +0% | +$1.02K | ﹤0.01% | 1626 |
|
|
2019
Q4 | $14.7M | Buy |
207,373
+11,145
| +6% | +$808K | 0.01% | 1426 |
|
|
2019
Q3 | $14.7M | Buy |
196,228
+10,390
| +6% | +$881K | 0.01% | 1350 |
|
|
2019
Q2 | $15M | Buy |
185,838
+6,962
| +4% | +$490K | 0.01% | 1343 |
|
|
2019
Q1 | $12M | Buy |
178,876
+16,331
| +10% | +$1.24M | 0.01% | 1469 |
|
|
2018
Q4 | $12.1M | Buy |
162,545
+7,483
| +5% | +$618K | 0.01% | 1335 |
|
|
2018
Q3 | $14.3M | Buy |
155,062
+17,902
| +13% | +$1.71M | 0.01% | 1388 |
|
|
2018
Q2 | $13.5M | Sell |
137,160
-55,804
| -29% | -$6.24M | 0.01% | 1385 |
|
|
2018
Q1 | $21.5M | Sell |
192,964
-7,070
| -4% | -$792K | 0.02% | 949 |
|
|
2017
Q4 | $20.6M | Buy |
200,034
+1,293
| +0.7% | +$129K | 0.02% | 953 |
|
|
2017
Q3 | $18.7M | Buy |
198,741
+9,021
| +5% | +$712K | 0.02% | 979 |
|
|
2017
Q2 | $14.8M | Buy |
189,720
+6,907
| +4% | +$519K | 0.01% | 1076 |
|
|
2017
Q1 | $14.6M | Buy |
182,813
+42,923
| +31% | +$3.41M | 0.01% | 1043 |
|
|
2016
Q4 | $11M | Buy |
139,890
+7,200
| +5% | +$559K | 0.01% | 1177 |
|
|
2016
Q3 | $10.3M | Buy |
132,690
+6,028
| +5% | +$437K | 0.01% | 1148 |
|
|
2016
Q2 | $8.71M | Buy |
126,662
+6,608
| +6% | +$456K | 0.01% | 1180 |
|
|
2016
Q1 | $8.57M | Sell |
120,054
-288
| -0.2% | -$18.1K | 0.01% | 1138 |
|
|
2015
Q4 | $7.48M | Buy |
120,342
+5,476
| +5% | +$334K | 0.01% | 1222 |
|
|
2015
Q3 | $6.51M | Sell |
114,866
-12,338
| -10% | -$653K | 0.01% | 1299 |
|
|
2015
Q2 | $6.83M | Buy |
127,204
+6,456
| +5% | +$314K | 0.01% | 1339 |
|
|
2015
Q1 | $5.74M | Buy |
120,748
+1,700
| +1% | +$75.3K | 0.01% | 1410 |
|
|
2014
Q4 | $5.15M | Sell |
119,048
-7,556
| -6% | -$309K | 0.01% | 1422 |
|
|
2014
Q3 | $4.35M | Buy |
126,604
+553
| +0.4% | +$19.5K | 0.01% | 1485 |
|
|
2014
Q2 | $4.62M | Sell |
126,051
-31,540
| -20% | -$1.07M | 0.01% | 1469 |
|
|
2014
Q1 | $5.31M | Sell |
157,591
-9,914
| -6% | -$327K | 0.01% | 1294 |
|
|
2013
Q4 | $5.68M | Buy |
167,505
+3,332
| +2% | +$115K | 0.01% | 1152 |
|
|
2013
Q3 | $5.3M | Buy |
164,173
+4,012
| +3% | +$107K | 0.01% | 1130 |
|
|
2013
Q2 | $3.7M | Buy |
+160,161
| New | +$3.47M | 0.01% | 1307 |
|
Charles Schwab's CMD Position: Q2 2021 in Review
Charles Schwab sold out of Cantel Medical Corporation (CMD) in Q2 2021, closing a stake of 315,743 shares — an estimated $25.2M sold.
Charles Schwab first reported a position in CMD in Q2 2013 and held it in 32 quarters. The position peaked at $25.4M in Q4 2020. 0 funds tracked by Wall St. Rank hold CMD as of Q2 2021.
- Charles Schwab reported no remaining Cantel Medical Corporation position as of Q2 2021 after selling out during the quarter.
- Charles Schwab sold 315,743 Cantel Medical Corporation shares in Q2 2021, an estimated $25.2M.
- Charles Schwab first reported a position in Cantel Medical Corporation in Q2 2013 and held it in 32 quarters.
- Charles Schwab's Cantel Medical Corporation position peaked at $25.4M in Q4 2020.
- 0 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q2 2021.
Based on Charles Schwab's 13F filing for Q2 2021, filed 16 Aug 2021.